Identifying Disease Mechanisms Using Gene Networks as Priors
summary
A probabilistic graphical model combines per-variant harmfulness priors, aggregated coding scores and gene-level expression aberration scores, then ties genes together with a degree-corrected network prior implemented via loopy belief propagation. Simulations (mechanisms of 10–100 genes, varying sample size and noisy edges) show higher precision and robustness than greedy network methods that use precomputed p-values (dmGWAS/SKAT comparisons). Applied to TCGA breast cancer the pipeline estimates coding variants explain ~55% of cases, coding+regulatory joint hits ~15% and regulatory-only ~20%, and it highlights patient-level posterior gene probabilities in medulloblastoma cohorts.
AI-written summary · about
chapters (22)
- 0:00Intro
- 0:56Identifying genetic disease mechanisms
- 2:11Data that can be used to identify the mechanism
- 3:02Aggregation based methods
- 3:43Network based methods
- 4:12List methods
- 7:02Model of a genetic disease
- 8:53Method Overview
- 11:33Graphical model
- 12:23Network implementation
- 14:05Overcoming network complexities
- 16:51Key differences
- 18:21Simulation data
- 19:28Results: Simulated mechanism of 10 genes
- 23:18Results: sensitivity to the noise
- 24:15Robustness of the method
- 25:07Advantages
- 25:47Real data: TCGA breast cancer
- 26:27Comparing to other methods
- 28:27Luminal breast cancer findings
- 29:32Medulloblastoma
- 30:16SHH Predictions based on model
related talks
56mIntroduction to Cancer Bioinformatics III: Cancer Progression Networks
01h 19mAnalyzing Genetic Networks Using Neural Networks
33mUnderstanding Molecular Complexity for Precision Medicine
01h 06mIntroduction to Biological Network Analysis III: Identifying Network Modules
17mLeveraging Knowledge Graph and Imaging to Predict Gene–Disease Links in Cardiovascular Diseases
01h 31mIntroduction to Cancer Bioinformatics I: Inferring Genomic Variation from Tumor Sequencing Data
38mMixed and Covariate-Dependent Graphical Models
30mLeveraging Molecular Data for Drug Discovery
